| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |